Tiwari B. FDA Approved Durvalumab for Limited-Stage Small Cell Lung Cancer. Nep. J. Cancer [Internet]. 2025 Apr. 1 [cited 2025 Dec. 6];9(1):9-14. Available from: https://nepjol.info/index.php/njc/article/view/77006